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Vancomycin, an important antibiotic, is marketed as lyophilized powder. In the context of routine analysis of this 
product, the existence of a more advantageous and effective method is interesting. Thus, the objective of this work is to 
develop and validate a new analytical method, faster, low-cost, ecological and miniaturized for quantification of 
vancomycin in lyophilized powder using spectrophotometry in ultraviolet region. Buffer solution pH 6.8, quartz cuvette 
with capacity of 700 µL and 280 nm were chosen. The method proved to be linear in the range of 50-150 µg/mL 
(0.9997). The selectivity of the method was proven in two ways: The standard-sample overlay aimed to identify 
vancomycin in the sample; The forced degradation test (sample solutions prepared in 0.01 M HCl, 0.01 M NaOH and 
aqueous conditions and kept at 60 ºC by 8 hours, and UV 254 nm at ambient temperature during 24 hours) aimed to show 
the susceptibility of the method to consequently indicate the stability of the sample. It was precise in intraday (RSD 1.27 
%), interday (RSD 1.18 %) and between analysts (RSD 1.92 %) levels. It was robust when small variations were 
performed in seven important parameters (wavelength, cuvette, filtration step, dibasic and monobasic phosphate brand, 
ultrasound time and source of water). The accuracy was proved by the standard recovery test and showed mean recovery 
of 101.10 %. This method can be applied in routine analysis of quality control of vancomycin lyophilized powder and it 
is an effective, accessible and ecological alternative, which follows the Green Analytical Chemistry principles, 
presenting less waste generation, no use of toxic solvents, smaller sample volumes and required diluents, which impacts 
on the final cost of the analyzes. 
 






Vancomycin (Figure 1) is a glycopeptide antibiotic 
obtained naturally and the first uncovered in this class. Its 
mechanism of action comprises the disrupt of bacteria cell 
wall by interfering in the synthesis of the cell wall (1-2). 
It is indicated for the treatment of infections caused by 
Gram-positive bacterias, including Methicillin resistant 
Staphylococcus aureus (MRSA), and intestinal infections 
caused by Clostridium difficile (2-3). Due its low 
absorption through gastrointestinal tract, it is 
intravenously administrated to treat systemic infections 
(4). Only in case of diarrhea caused by Clostridium 
difficile, the oral via is required (5). It is mainly 
eliminated through renal tract, what can lead to 
nephrotoxicity in people with renal disease, making 
necessary to adjust the dosage (3). Due the development 
of MRSA, vancomycin became the only drug to be used 
in the treatment of infections caused by this 
microorganism (6). It is also used as an alternative in case 
of allergy to penicillin (7-8). 
The development of analytical methods is of great 
importance for the quality control of drugs in 
pharmaceutical industries, it is a way to assure the safety 
and efficacy of the drug. The spectrophotometric method 
by UV is simple and easy to perform, besides it is low 
cost and provides precise results in quantitative analysis 
of drugs (9-10). It was found some methods in literature 
for quantification of this drug using the 
spectrophotometry in UV region (11-17), however they 
do not bring the Green Analytical Chemistry proposal.  
 
 
Figure 1. Chemical structure of vancomycin (CAS 1404-90-6). 
 
According to the official compendia, British 
Pharmacopoeia (18) and American Pharmacopoeia (19) 
recommend HPLC and agar diffusion method. Japanese 
Pharmacopoeia (17) recommends UV (but not on a 
miniaturized scale and greater amount of drug 100 
µg/mL) and agar diffusion method. Besides the use of no 
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toxic solvents, it is possible to make these methods 
become greener, following the Green Analytical 
Chemistry principles (20-22). One alternative is the 
miniaturized analyzes, which are made using smaller 
amounts of sample and standard volume, as well as 
diluents, which generates less waste, makes the methods 
more economical and dynamic (23-27). 
So, the objective of this work is to develop a miniaturized 
method by spectrophotometric in UV region for 




Materials and reagents 
 
The reference standard (secondary standard) was 
vancomycin, content 96.3 %, and pharmaceutical form 
(sample) was vancomycin in lyophilized powder for 
injection 500 mg (labeled content). They were kindly 
donated by ABL Antibióticos do Brasil (Cosmópolis, São 
Paulo, Brazil). 
The reagents used were purified water (water purification 
system (Millipore™), potassium phosphate dibasic 
(Sigma™) and monobasic (Synth™), to prepare the 





The equipment used was a Spectrophotometer UV mini-
1240 (Shimadzu™), quartz cuvettes with 1 cm optical 
path and capacity of 700 µL, analytical balance model 
DV215CD (Ohaus™), water purification system 





The solutions of vancomycin reference and sample were 
prepared in buffer pH 6.8. An amount of 5.19 mg of 
vancomycin reference was weighted and transferred to a 
25 mL volumetric flask with buffer pH 6.8 and submitted 
to an ultrasound bath during five minutes to complete 
dissolution, and then completed the volume with the same 
diluent in order to obtain a reference solution of 200 
µg/mL. This stock solution was filtered through a filter 
paper and an aliquot of 2.5 mL was taken and transferred 
to a 5 mL volumetric flask and completed with buffer, 
giving a solution of 100 µg/mL. 
The sample solution was prepared considering the 
average weight from twenty vials of vancomycin (504.82 
mg) and an amount of 5.05 mg of vancomycin sample 
was weighted and transferred to a 25 mL volumetric flask 
with buffer pH 6.8 and submitted to ultrasound bath 
during five minutes until complete dissolution, and then 
the volume was completed with the same diluent to reach 
a solution with concentration of 200 µg/mL. This stock 
solution was also filtered by a filter paper and an aliquot 
of 2.5 mL was taken and transferred to a 5 mL volumetric 
flask and completed with buffer, giving a solution of 100 
µg/mL. Spectra were obtained from scanning in the 




The Ringbom curve was obtained by the determination of 
the absorbance of 33 standard concentrations of 
vancomycin at 280 nm, in order to determine the linear 
concentration range. 
An amount of 103.84 mg of vancomycin reference was 
weighted and transferred to a 200 mL volumetric flask 
with buffer pH 6.8 and submitted to ultrasound bath by 
five minutes, and then completed the volume with the 
same diluent to reach a solution of 500 µg/mL. This stock 
solution was filtered using a filter paper and the aliquots 
were taken in order to prepare 33 solutions, which varied 




The validation procedure was performed according to the 
International Conference of Harmonization (28) 
specifications for linearity, selectivity, limits of detection 






From the Ringbom curve 6 concentrations were chosen 
for evaluation of the linearity of the method. For this, 
10.38 mg of vancomycin reference (equivalent to 10 mg 
of vancomycin) was weighted and transferred to a 50 mL 
volumetric flask with buffer pH 6.8 and submitted to 
ultrasound bath by five minutes, and then the volume was 
completed with the same diluent to reach a solution of 
200 µg/mL. From this stock solution, aliquots were taken 
to prepare the solutions of 50, 70, 90, 110, 130 and 150 
µg/mL. The absorbance was measured at 280 nm. The 
linearity was performed in three different days and in 
triplicate.  
The data obtained were evaluated by regression analysis. 
The equation of the line was determined by linear 
regression analysis by the method of the least squares. 
The Analysis of Variance (ANOVA) was also performed 




The selectivity of the method was determined by the 
response obtained for vancomycin solutions reference and 
sample. It was also proved by the forced degradation test, 
where the vancomycin solution was prepared in 0.01 M 
HCl, 0.1 M NaOH, H2O2 0.3 % and in water at a 
concentration of 100 µg/mL and submitted to water bath 
at 60 ºC. Aliquots of these solutions were taken at 2, 4, 6 
and 8 hours and the absorbance were measured, as well as 
the absorbance profile. Additionally, a solution of 
vancomycin was prepared in buffer at a concentration of 
100 µg/mL and submitted to UV light (254 nm), and 
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aliquots of this solutions were taken at 2, 4, 6, 8 and 24 
hours and immediately analyzed. 
 
Limits of detection and quantification 
 
The limits of detection and quantification were obtained 
from the three calibration curves of the linearity, using the 





   Equation 1 
LOQ= 10 𝑥 
𝑆𝐷
𝑎
   Equation 2 
 
SD: standard deviation 





Precision was evaluated by the repeatability and the 
intermediate precision. The repeatability was performed 
using six replicates of the same concentration (90 µg/mL) 
in the same day, with the same analyst, under the same 
conditions of analysis. The intermediate precision was 
performed by another analyst on a different day, under the 
same conditions of the method. The precision was 
analyzed by RSD (%) values. It was considered precise 




The robustness of the method was performed according to 
Youden & Steiner test (29), where seven fundamental 
analytical parameters were chosen and small variations 
were performed. The parameters chosen were: 
wavelength, cuvette, filtration step, dibasic and 
monobasic phosphate brand, ultrasound time and source 
of water. The method was considered robust when the 




The accuracy of the method was demonstrated by the 
recovery test, in triplicate and in three levels, 80, 100 and 
120%, considering 100 µg/mL (100%). A standard stock 
solution was prepared in the concentration of 1000 
µg/mL. A sample solution was also prepared in the same 
concentration. From the sample solution, aliquots of 500 
µL were taken and transferred to 10 mL volumetric flask 
(50 µg/mL). Then, from the reference stock solution 
aliquots of 300, 500 and 700 µL were transferred to 10 
mL volumetric flasks containing the sample aliquot, in 
order to obtain a final concentration of 80, 100 and 120 
µg/mL, respectively. The mean recoveries, expressed in 
terms of percentage of standard recovered and RSD (%), 
were determined. It was considered accurate when 
recovery was between 98-102% and RSD (%) values 





The solutions preparations were made in accordance with 
item 2.3. and absorbance was measured. The values of 
average absorbance for each solution were compared 
using the Equation 3. 
 
Cs= As x 
𝐶𝑟
𝐴𝑟
   Equation 3 
 
Cs: concentration of sample solution; As: absorbance of 
sample solution; Cr: concentration of reference solution; 
Ar: absorbance of reference solution. 
 
It was considered adequate when content was between 
90-115% (17). 
 




Vancomycin spectrum in the region of 200 to 400 nm 
showed better absorption at a wavelength of 280 nm and 
it was used in the Ringbom curve to define the validation 
concentrations. In the comparison between purified water 
and buffer pH 6.8, as diluent, the buffer showed better 
absorbance values when the same vancomycin 
concentration was used. 
The Ringbom curve obtained is shown in Figure 2. Six 
concentrations, 50 to 150 µg/mL, were chosen from this 
curve to perform the linearity of the method. 
 
 




An appropriate amount of standard vancomycin was 
diluted in buffer pH 6.8 in order to obtain work solutions 
of 50-150 µg/mL. The data were validated by ANOVA 
(Table 1), which showed significant linear regression 
(Fcalculated > Fcritical, p =0.05), and no significant lack 
of fit (Fcalculated < Fcritical, p=0.05), in this way, the 




The selectivity of the method was analyzed by comparing 
the spectra of vancomycin solutions reference and 
 
Nascimento PA et al. / Drug Anal. Res., v. 5, n. 1, p. 39-45, 2021 
 
42 
sample, which overlapped perfectly and allowed to 
identify vancomycin in the analyzed sample (Figure 3). 
 
Table 1. ANOVA results for linearity of the method proposed. 
Parameters 280 nm 
Linearity range (µg/mL) 50-150 
Slope 0.0044 
Intercept 0.0018 
Correlation coefficient (r) 0.9994 
Regression 1385.72 (4.75) 




Figure 3. Overlap of vancomycin reference and sample spectra 
at a concentration of 100 µg/mL. 
 
It was also analyzed by the spectra obtained in the forced 
degradation test. The vancomycin solution was submitted 
to acidic, alkaline, oxidative, aqueous and photolytic 
media and in all conditions the band of maximum 
absorbance of vancomycin was smaller when compared to 
the spectra obtained in time 0 (Table 2), showing the 
susceptibility of the method and its capacity to indicate 
stability. In a study by HPLC (31), vancomycin in 
lyophilized powder was degraded under the same forced 
conditions as this work and the results (after the same 
periods of time) also showed the susceptibility of the 
method and its ability to indicate the stability of the 
sample. After all, forced degradation studies challenge the 
method, which must be able to reveal the true situation of 
the drug. 
In this context, the spectrum obtained in the oxidative 
condition showed relevant tracing distortion, which may 
be due to the possible degradation of the drug and the 
appearance of degradation products, as revealed in the 
study by HPLC (31), or to the interference of the 
preservative present in the solution of H2O2, also seen in 
other studies of forced degradation analyzed by UV (32-
33). And, even in this context, the unchanged tracings of 
the other degradations may be suggestive of a small 
instability of the molecule (results shown in Table 2), 
which corroborates the results by HPLC (31). 
 
Table 2. Absorbance values at 280 nm and percentual decrease 
of vancomycin sample after the degradation conditions 




time 0  
Abs time  




HCl 0.01 M – 60 ºC 0.448 0.441 1.56 
NaOH 0.1 M – 60 ºC 0.450 0.422 6.22 
H2O2 0.3% - 60 ºC 0.626 0.595 4.95 
H2O – 60 ºC 0.446 0.418 6.28 
UV 254 nm 0.443 0.414 6.55 
*24-hour time for photolytic degradation only. 
 
It is valid to attest that the evaluation was made at 280 
nm, which was the wavelength chosen in the development 
of the method for vancomycin. The spectra of each 
degradation in time 0 and after 8 hours, for acidic, 
alkaline, oxidative and aqueous degradation, and after 24 
hours for photolytic degradation test are shown in Figure 
4. 
 
Limits of detection (LOD) and quantification (LOQ) 
 
The LOD and LOQ obtained were, respectively, 0.72 and 
2.19 µg/mL. The limits are low what shows the sensibility 




Precision was proved by the repeatability showing RSD 
of 1.27 % and by intermediate precision showing RSD of 
1.92 %. Both precisions showed adequate results of RSD 
(%) being smaller than 2.00 %, so the method can be 
considered precise. The results for repeatability and 




The robustness of the method was performed by Youden 
& Steiner test (29). The effects, as well as the SD x √2, 
are shown in Table 4. As the effects show a value below 
3.25, the modifications studied in each parameter do not 








Figure 4. Spectra of vancomycin in time 0 (red) and time 8 hours (black) at acidic (a), alkaline (b), oxidative (c) and aqueous 
(d) conditions, and after 24 hours at photolytic (e) media, all at a concentration of 100 µg/mL. 
 
Table 3. Precision results for miniaturized method by UV for vancomycin. 




 1 2 3 4 5 6  
Repeatability 0.400 a 0.410 a 0.407 a 0.409 a 0.416 a 0.407 a 1.27 
Intermediate 
0.404 b 0.402 b 0.399 b 0.405 b 0.390 b 0.392 b 
1.92 
0.390 c 0.400 c 0.390 c 0.392 c 0.395 c 0.389 c 
a: Absorbance obtained by analyst 1 in one day of analysis; b: Absorbance obtained by analyst 1 in two days of analysis; c: Absorbance 
obtained by analyst 2 in two days of analysis. 
 
Table 4. Robustness of the miniaturized method by UV for vancomycin. 




RSD x √𝟐 
Wavelength (nm) 280 282 2.84   
Cuvette (mL) 0.7 2.5 -0.23   
Filtration Yes No 0.91   
Dibasic phosphate brand Sigma Qhemis -1.70 2.30 3.25 
Monobasic phosphate brand Synth Vetec 1.70   
Ultrasound time (min.) 5 3 0.91   




The accuracy of the developed method was determined by 
recovery of standard. The recoveries are shown in the 
Table 5, as well as the RSD (%) values. The method can 
be considered accurate, considering the mean recovery in 
three days of analysis, in accordance to 98-102%, as 
specified by AOAC and Horwitz trumpet (30, 34) and 
RSD (%) values below 2.00%. 
 


















R1 30 30.14 100.47   
R2 50 50.79 101.57 101.10 0.50 
R3 70 70.87 101.25   
 





The content analysis of vancomycin sample is shown in 
Table 6. Dosing was carried out in three days and in 
triplicate in order to obtain the vancomycin content in the 
pharmaceutical product. In addition, it is possible to 
confirm that the content is in accordance with the 
established in the monograph, which establishes content 
of 90–115% (17). The average content of vancomycin 
obtained in the final product was 95.65% and is in line 
with the recommended. 
 
Table 6. Content analysis for vancomycin lyophilized powder 









95.65** 0.99 2 96.12 
3 96.26 
* Average of 3 determinations. 
** Content within the specification as recommended by the 
Japanese Pharmacopoeia of 90 to 115 % (17). 
 
The UV spectrophotometric method developed for 
quantification of vancomycin was validated according to 
the parameters established in ICH guidelines (28). The 
method can be considered ecological, since: 
• it uses no toxic solvents = buffer solution pH 6.8 
• it uses less quantity of diluents, reagents and sample = 
700 µL 
• it is a simple and easy method to be performed = 
spectrophotometry in the ultraviolet region 
• it is a fast method, showing results in a short period of 
time = seconds 
The analytical conditions chosen make the method 
advantageous and part of the Green Analytical Chemistry, 
being dynamic, miniaturized and ecological with a small 
generation of residues, which contributes positively to the 




There is a gap in the literature of articles for the 
evaluation of vancomycin pharmaceutical products by 
UV on a miniaturized scale and that can be used in 
routine analyzes, as proposed. In the present work an 
effective, accessible and ecological alternative method by 
spectrophotometry in UV region was developed for 
vancomycin in lyophilized powder. It presents less waste 
generation, does not use toxic solvents, requires smaller 
sample volumes and diluents, which impacts on the final 
cost of the analyzes. The method proved to be linear in 
the range of 50 to 150 µg/mL, selective, precise, robust 
and accurate, being a greener alternative that can be 
applied in the routine quality control process of 
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